FDA inspection
Qilu Pharmaceutical Hulun Buir Branch: FDA inspection ending Aug 25, 2023
FDA inspection 1219574 · No Action Indicated (NAI) · Hulun Beier
Key facts
| Inspection ID | 1219574 |
|---|---|
| Firm | Qilu Pharmaceutical Hulun Buir Branch |
| FEI number | 3024070938 |
| Address | Qidaocun Liuhezhen Arongqi, Buir |
| City | Hulun Beier |
| Country | China |
| Fiscal year | 2023 |
| Inspection end date | Aug 25, 2023 |
| Classification | No Action Indicated (NAI) |
| Project area | Pre-Approval Eval. of Animal Drugs and Food Additives |
| Product type | Veterinary |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data